Global Therapeutic Vaccines Market 2019-2023
SKU ID : TNV-14326686 | Publishing Date : 30-May-2019 | No. of pages : 123
Detailed TOC of Global Therapeutic Vaccines Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY TYPE
Market segmentation by type
Comparison by type
Cancer vaccines - Market size and forecast 2018-2023
Infectious diseases vaccines - Market size and forecast 2018-2023
Other diseases vaccines - Market size and forecast 2018-2023
Neurological diseases vaccines - Market size and forecast 2018-2023
Autoimmune diseases vaccines - Market size and forecast 2018-2023
Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Market trends
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Aimmune Therapeutics, Inc.
Immune Response BioPharma Inc.
Inovio Pharmaceuticals Inc.
Novartis AG
Sanpower Group Co. Ltd.
PART 14: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global vaccine market
Exhibit 02: Segments of global vaccine market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Cancer vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Cancer vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 21: Infectious diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Infectious diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 23: Vaccines under development for infectious diseases
Exhibit 24: Other diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Other diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 26: Vaccines under development for other diseases
Exhibit 27: Neurological diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Neurological diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 29: Vaccines under development for neurological diseases
Exhibit 30: Autoimmune diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Autoimmune diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 32: Vaccines under development for autoimmune diseases
Exhibit 33: Market opportunity by type
Exhibit 34: Customer landscape
Exhibit 35: Market share by geography 2018-2023 (%)
Exhibit 36: Geographic comparison
Exhibit 37: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: North America - Year-over-year growth 2019-2023 (%)
Exhibit 39: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 41: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 42: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 43: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 44: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 45: Key leading countries
Exhibit 46: Market opportunity
Exhibit 47: Vaccines under development
Exhibit 48: Impact of drivers and challenges
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: Aimmune Therapeutics Inc. - Vendor overview
Exhibit 55: Aimmune Therapeutics Inc. - Business segments
Exhibit 56: Aimmune Therapeutics Inc. - Organizational developments
Exhibit 57: Aimmune Therapeutics Inc. - Key offerings
Exhibit 58: Immune Response BioPharma Inc. - Vendor overview
Exhibit 59: Immune Response BioPharma Inc. - Key offerings
Exhibit 60: Inovio Pharmaceuticals Inc. - Vendor overview
Exhibit 61: Inovio Pharmaceuticals Inc. - Product segments
Exhibit 62: Inovio Pharmaceuticals Inc. - Organizational developments
Exhibit 63: Inovio Pharmaceuticals Inc. - Key offerings
Exhibit 64: Novartis AG - Vendor overview
Exhibit 65: Novartis AG - Business segments
Exhibit 66: Novartis AG - Organizational developments
Exhibit 67: Novartis AG - Geographic focus
Exhibit 68: Novartis AG - Segment focus
Exhibit 69: Novartis AG - Key offerings
Exhibit 70: Sanpower Group Co. Ltd. - Vendor overview
Exhibit 71: Sanpower Group Co. Ltd. - Key offerings
Exhibit 72: Validation techniques employed for market sizing
Exhibit 73: Definition of market positioning of vendors
Keyplayers in Global Therapeutic Vaccines Market 2019-2023
Aimmune Therapeutics Inc.Immune Response BioPharma Inc.
Inovio Pharmaceuticals Inc.
Novartis AG
Sanpower Group Co. Ltd.